Dear 222 News viewers, sponsored by smileband,
Sickle Cell Day Unit at Royal London Hospital to Reopen After Public Campaign Garners 44,000+ Signatures
After mounting pressure from patients, campaigners and the wider public, the Sickle Cell Day Unit at The Royal London Hospital in Whitechapel, London is set to reopen — a decision hailed as a major win for healthcare equity and community-led action.
A Vital Service Under Threat
The specialist Sickle Cell Day Unit, which provides urgent care specifically tailored to people living with sickle cell disease (SCD), had closed its doors earlier this year following the end of a six-month pilot scheme. The unit offered an alternative to long waits in overcrowded A&E departments, helping patients in pain crises receive rapid, expert treatment from clinicians experienced in managing the condition.
Sickle cell disease is a lifelong genetic blood disorder that can cause severe pain, organ damage and life-threatening complications. It disproportionately affects people of African and Caribbean heritage, with around 15,000–17,000 people living with the condition in England.
44,000 Signatures and Growing Support
Concern over the closure sparked a wave of public support, culminating in a petition launched by campaigner Delo Biye. In just a short period, the petition gathered more than 44,000 signatures, highlighting widespread backing for specialist sickle cell care and saying loud and clear that the community relied on the unit’s services.
Supporters shared stories of how the unit meant faster pain relief, fewer complications and a more humane experience for patients who too often felt overlooked in standard emergency care settings. Many warned that without specialist provision, people in crisis could face long waits in A&E and less targeted treatment.
Response from Health Authorities
In response to the campaign, Barts Health NHS Trust confirmed that the unit will reopen and remain a key part of services for sickle cell patients. Additional funding has been secured to extend specialised provision, including same-day care options that help reduce unnecessary hospital admissions and pressure on emergency departments.
Advocates say this decision marks a significant recognition by health leaders of the unique needs of people living with sickle cell disease. It also underscores how public pressure and collective voices can influence NHS planning and priorities — especially for conditions that historically have received less attention and resources.
What This Means for Patients
For many living with sickle cell disease, the reopening of the day unit is more than just a healthcare service restored — it’s reassurance that their health needs are valued and understood. Specialist units like this bring clinicians trained in sickle cell care, faster assessments during pain crises, and an environment designed around the experiences of people affected by the condition.
Patient groups and charities, including the Sickle Cell Society, have welcomed the news but continue to call for long-term investment in specialist care, training and wider awareness across the NHS to ensure all sickle cell patients receive timely, high-quality care wherever they present.
Attached is a News article regarding sickle cell disease
https://www.bbc.co.uk/news/topics/c7rww4lvl67t
Article written and configured by Christopher Stanley
Google tag (gtag.js) --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-XDGJVZXVQ4"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-XDGJVZXVQ4'); </script>
<script src="https://cdn-eu.pagesense.io/js/smilebandltd/45e5a7e3cddc4e92ba91fba8dc
